CIK 0001281895
- Non-accelerated filer
- Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $411,605
- in 5 filings
Net −$411,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 48 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-18 | BOESS CARSTEN Director | Grant or award | +22,862 | 52,862 | ||
| 2026-06-18 | BOESS CARSTEN Director | Grant or award · Stock Option (Right to Buy) | +64,860 | 64,860 | ||
| 2025-06-18 | BOESS CARSTEN Director | Grant or award | +30,000 | 30,000 | ||
| 2024-06-13 | BOESS CARSTEN Director | Grant or award · Stock Option (Right to Buy) | +23,944 | 23,944 | ||
| 2023-06-22 | BOESS CARSTEN Director | Grant or award · Stock Option (Right to Buy) | +25,850 | 25,850 | ||
| 2022-06-13 | BOESS CARSTEN Director | Grant or award · Stock Option (Right to Buy) | +47,745 | 47,745 | ||
| 2021-06-14 | BOESS CARSTEN Director | Grant or award · Stock Option (Right to Buy) | +12,236 | 12,236 | ||
| 2020-06-16 | BOESS CARSTEN Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-01-28 | BOESS CARSTEN Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2018-03-29 | BOESS CARSTEN Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 |
Page 1 of 1 · 10 trades